KRAS and malignant colon neoplasm: We analyzed the changes in SLC7A7 and gene mutations, acquisitions, and deletions in colon cancer, the difference in APC, TTN, KRAS, SYNE1, RYR2, and LRP1 mutations was statistically significant (Fig. 4F).